234 related articles for article (PubMed ID: 19835465)
1. Analysis of the impact and burden of illness of adult chronic ITP in the US.
Saleh MN; Fisher M; Grotzinger KM
Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
[TBL] [Abstract][Full Text] [Related]
2. A retrospective observational single-centre study on the burden of immune thrombocytopenia (ITP).
Bauer M; Baumann A; Berger K; Ackermann B; Shlaen R; Schopohl D; Ostermann H
Onkologie; 2012; 35(6):342-8. PubMed ID: 22722454
[TBL] [Abstract][Full Text] [Related]
3. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
4. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
Glanz J; France E; Xu S; Hayes T; Hambidge S
Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
[TBL] [Abstract][Full Text] [Related]
5. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
6. Treatment practices in adults with chronic immune thrombocytopenia - a European perspective.
Rodeghiero F; Besalduch J; Michel M; Provan D; Grotzinger K; Thompson G
Eur J Haematol; 2010 Feb; 84(2):160-8. PubMed ID: 19845743
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
Simpson KN; Coughlin CM; Eron J; Bussel JB
Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
[TBL] [Abstract][Full Text] [Related]
8. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Hoy T; Singhal PK; Willey VJ; Insinga RP
Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
[TBL] [Abstract][Full Text] [Related]
9. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
[TBL] [Abstract][Full Text] [Related]
10. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
11. Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis.
Khellaf M; Le Moine JG; Poitrinal P; Francesconi C; Haddad A; Bierling P; Michel M; Eckert L; Launois R; Godeau B
Ann Hematol; 2011 Apr; 90(4):441-6. PubMed ID: 20922528
[TBL] [Abstract][Full Text] [Related]
12. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
13. Impact of ITP on physician visits and workplace productivity.
Tarantino MD; Mathias SD; Snyder CF; Isitt JJ; Gernsheimer T; Young J
Curr Med Res Opin; 2010 Feb; 26(2):319-28. PubMed ID: 19968458
[TBL] [Abstract][Full Text] [Related]
14. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
15. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
16. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
17. Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients.
Poordad F; Theodore D; Sullivan J; Grotzinger K
J Med Econ; 2012; 15(1):112-24. PubMed ID: 21995622
[TBL] [Abstract][Full Text] [Related]
18. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
19. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
Shah M; Butler M; Bramley T; Curtice TG; Fine S
Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
